GSCAFATVEDYLH, corresponding to C terminal amino acids 717-729 of Human RanBP9.
Our Abpromise guarantee covers the use of ab5295 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|IP||Use at an assay dependent concentration. PubMed: 21561988|
|ELISA||Use at an assay dependent dilution. Peptide ELISA: Antibody detection limit dilution 1:16,000|
|IHC-P||Use at an assay dependent concentration.|